Augmentation of T and B Cell Activation with a Novel Cysteine Protease Linker Sequence
Invention type: Technology
/
Case number: #25338
Researchers
Departments: Biology, David H Koch Institute for Integrative Cancer Res
Technology Areas: Chemicals & Materials: Nanotechnology & Nanomaterials / Therapeutics: Nucleic Acids, Proteins & Antibodies, Vaccines
Impact Areas: Healthy Living
-
augmentation of t and b cell activation with specific cysteine protease linker sequences
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.